Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis
Peter W.F. Wilson, M.D., Jeffrey M. Hoeg, M.D., Ralph B. D'Agostino, Ph.D., Halit Silbershatz, Ph.D., Albert M. Belanger, M.A., Harold Poehlmann, M.S., Daniel O'Leary, M.D., and Philip A. Wolf, M.D.
Background Single measurements of cardiovascular risk factorsmay not accurately reflect a person's past exposure to thoserisk factors. We therefore studied the long-term associationsof cardiovascular risk factors such as high serum cholesterollevels, high blood pressure, and cigarette smoking with theprevalence of carotid stenosis.
Methods We studied cross-sectional and longitudinal informationfrom a sample of 429 men and 661 women in the Framingham HeartStudy who underwent B-mode ultrasound measurements of the carotidartery. Their mean age was 75 years, and each had attended mostof the biennial clinic examinations over the 34 years beforethe carotid ultrasound study. We used time-integrated measurementsto assess the associations between various cardiovascular riskfactors and the degree of carotid stenosis.
Results Moderate carotid stenosis (>25 percent) was presentin 189 men and 226 women. We assessed the odds ratios for thisdegree of stenosis as compared with minimal stenosis (<25percent) according to increases in risk factors. In the men,the odds ratio for moderate carotid stenosis associated withan increase of 20 mm Hg in systolic blood pressure was 2.11(95 percent confidence interval, 1.51 to 2.97). The odds ratiofor an increase of 10 mg per deciliter (0.26 mmol per liter)in the cholesterol level was 1.10 (95 percent confidence interval,1.03 to 1.16), and for an increase of five pack-years of smokingit was 1.08 (95 percent confidence interval, 1.03 to 1.13).The results were similar in the women. Time-integrated measurementsof diastolic blood pressure showed significant associationswith carotid stenosis in men and insignificant associationsin women.
Conclusions Over the long term, high systolic blood pressure,high cholesterol levels, and smoking were associated with anincreased risk of carotid stenosis in this elderly population.
The effect of risk factors such as high levels of serum cholesteroland high-density lipoprotein (HDL) cholesterol, high blood pressure,and cigarette smoking on the incidence of coronary disease inmiddle-aged people has been well described.1,2,3 Less certain,however, is the role of these risk factors in older people andthe degree to which they are associated with vascular abnormalitiesdetected by noninvasive techniques.4,5,6 Cross-sectional studiesof these traditional risk factors, accompanied by assessmentsof carotid stenosis by ultrasound techniques, are beginningto delineate the effect of these biochemical, biologic, andbehavioral factors on the atherosclerotic process.
Interest in screening carotid arteries has increased as studieshave demonstrated that carotid endarterectomy can prevent strokein symptomatic persons with more than 70 percent stenosis7,8and in asymptomatic persons with at least 60 percent stenosis.9Data from most cross-sectional studies have shown that clinicalfactors measured at the time of noninvasive testing, such asblood pressure, total cholesterol, HDL cholesterol, and smoking,are not highly associated with stenosis,10,11 although reportsbased on data from middle-aged adults suggest that abnormallevels of traditional risk factors are associated with greaterthickness of the intima of the carotid artery.5,12,13,14,15,16Authors have noted that the measurement of a risk factor ata single point in time may not accurately reflect a person'spast exposure to that factor. This may be particularly importantfor older people, among whom weight loss, declining health,and a decline in some risk factors are prevalent.17,18
Since total cholesterol levels typically peak in middle ageand decline in the elderly, single evaluations of risk factorsmay underestimate associations with clinical or subclinicalvascular disease in older people.17 With these issues in mind,we undertook the present study, in which we compared currentmeasurements, using summary time-integrated estimates of riskfactors, with the degree of carotid stenosis as determined byB-mode ultrasonography.
Methods
Subjects and Measurement of Risk Factors
Subjects considered for this investigation were surviving membersof the original cohort of the Framingham Heart Study who participatedin examination 20 (19881989) and had carotid ultrasoundexaminations performed. During the clinic visit, a history wasobtained and a physical examination was performed. Persons whoreported having smoked cigarettes during the previous year wereclassified as smokers and were asked a follow-up question aboutthe number of cigarettes they smoked per day on a regular basis.Blood pressure was measured after subjects had been seated forat least five minutes. Two blood-pressure measurements weretaken, and the average values were used in the analyses. Bloodwas drawn from nonfasting subjects, and cholesterol and HDLcholesterol were measured by enzymatic assays.19
Over the course of the previous 34 years (biennial examinations3 through 19), the cholesterol levels of the study participantswere measured at 11 examinations. Nonenzymatic laboratory methodswere used until examination 20.20 The third biennial examinationwas used as the base line for this study because of previouslyreported regression to the mean in risk-factor measurements,which was particularly evident for blood pressure shortly afterthe study's inception.21 Of the subjects whose cholesterol wasmeasured and whose carotid arteries were evaluated at examination20 (1189 subjects), only those who had attended six or moreof the examinations at which cholesterol was measured were consideredfor this study (1090 subjects). Nonfasting cholesterol levelswere determined at all but the 11th examination,20 HDL cholesterolwas measured at the 11th and 15th examinations, and blood pressureand the number of cigarettes smoked daily were recorded at allexaminations. Each subject's exposure to each of these factorsbefore the carotid evaluation was determined on the basis ofthe mean levels for that subject over the course of the study;antecedent averages for blood pressure, smoking, and total cholesterolwere calculated from examinations 3 to 19, and averages forHDL cholesterol and the ratio of total to HDL cholesterol fromexaminations 11 and 15. The summary variable for smoking wasdetermined by calculating the number of pack-years each subjectsmoked during the observation period.
Ultrasonography
A total of 1090 subjects underwent ultrasonography with an Ultrasonixhigh-resolution, real-time scanner with a 7.5-MHz imaging transducer,a 4-MHz pulse-wave Doppler transducer, and a 4-MHz continuous-wavetransducer.4 Projections of the carotid bifurcation were obtainedon each side at three locations: the distal 1 cm of the commoncarotid artery, the carotid bulb, and the proximal 1 cm of theinternal carotid artery. Frozen images, captured on a Mitsubishipage printer, and short segments of real-time scanning to demonstratemotion were recorded on videotape for later interpretation.Continuous-wave Doppler recording of the external carotid arteryand both pulse-wave and continuous-wave recording of the carotidbifurcation exclusive of the external carotid artery were obtainedat the site of maximal disturbance of flow.
Plaque thickness was measured with hand-held calipers in thenear and far walls, exclusive of the external carotid artery,at the site of maximal disease in each view. The total plaquethickness was calculated by combining the measurements for thenear and far walls. The residual lumen was measured at the siteof maximal luminal narrowing, and the unobstructed lumen wasmeasured just distal to the site of any wall abnormality. Peaksystolic velocities and frequencies were recorded at the sitesof maximal flow disturbance. The degree of vascular stenosiswas estimated by a composite of both Doppler spectral criteriaand assessment of gray-scale images. The maximal percent stenosisof the two arteries was used for this report.4
Quality control for the carotid measurements included secondexaminations and readings for 25 subjects within three monthsof their original evaluations. After estimation of the degreeof maximal carotid stenosis in increments of 5 percent, thePearson correlation coefficient for the method was 0.89. Whenthe maximal carotid stenosis was categorized according to percentage(0, 1 to 24, 25 to 49, and >50 percent), the intraclass correlationcoefficient was 0.86 (95 percent confidence interval, 0.72 to0.93).
Statistical Analysis
Statistical methods included a general linear regression model,with adjustment for age, to compare mean levels of the riskfactors22 and age-adjusted logistic regression to test for associationsbetween moderate (>25 percent) and minimal (<25 percent)carotid stenosis.23 Similar age-adjusted logistic-regressionanalyses were also undertaken to compare severe (>50 percent)with less severe (<50 percent) carotid stenosis. The adultaverage levels of cholesterol, HDL cholesterol, blood pressure,and smoking at earlier examinations were calculated for eachsubject within each carotid-stenosis category, and separateanalyses were performed for men and women.
Results
Mean (±SE) risk-factor levels are shown in Table 1 accordingto the degree of stenosis. The relative frequency of specificcurrent risk-factor levels is shown in Table 2. For instance,there were 90 men with 0 percent stenosis, of whom 54 percenthad systolic pressures of 140 mm Hg or higher and 23 percenthad diastolic pressures of 90 mm Hg or higher.
Table 2. Distribution of Current Risk-Factor Categories According to the Degree of Carotid Stenosis, 1987 to 1989.
The associations of risk factors with the presence of at least25 percent carotid stenosis as compared with less than 25 percentstenosis are shown in Table 3. The values in the tables representthe estimated age-adjusted effects of specified differencesin given variables. For instance, among women the estimatedodds ratio for at least 25 percent carotid stenosis associatedwith an increase of 20 mm Hg in systolic blood pressure was1.16 (95 percent confidence interval, 1.02 to 1.35); for anincrease of 20 mm Hg in diastolic pressure it was 0.60 (95 percentconfidence interval, 0.44 to 0.82), and for current smokingit was 2.60 (95 percent confidence interval, 1.57 to 4.30).A positive association with systolic pressure and an inverseassociation with diastolic pressure were evident in women whencurrent blood-pressure levels were used in the analysis. Noneof the current risk-factor levels were associated with carotidstenosis of at least 25 percent in men.
Table 3. Age-Adjusted Odds Ratios for >25 Percent versus ,25 Percent Carotid Stenosis, According to Current and Time-Integrated Risk-Factor Levels.
Associations between the time-integrated risk-factor levelsand moderate carotid stenosis appear in Table 3. There weresignificant associations among men and women for systolic pressureand total cholesterol. For instance, among men the odds ratiofor at least 25 percent carotid stenosis that was associatedwith an increase of 20 mm Hg in systolic blood pressure was2.11 (95 percent confidence interval, 1.51 to 2.97), and foran increase of 10 mg per deciliter in cholesterol it was 1.10(95 percent confidence interval, 1.03 to 1.16). The time-integratedmeasurements of systolic pressure and cholesterol generallyshowed higher degrees of association with carotid stenosis thanwere evident for the levels that had been measured at the timeof the carotid evaluations. The degree of association betweenthe time-integrated measurement of cigarette smoking and moderatecarotid stenosis was generally similar to the result obtainedwith the measurement of current smoking. The associations betweenmoderate carotid stenosis and time-integrated measurements ofdiastolic pressure were generally positive, in contrast to whatwas observed for current levels of diastolic pressure. Time-integratedmeasurements of the ratio of total cholesterol to HDL cholesterolwere associated with moderate carotid stenosis in women, forwhom the odds ratio associated with a one-unit increase was1.19 (95 percent confidence interval, 1.05 to 1.34), but theresult was not significant in men, for whom the correspondingodds ratio was 1.07 (95 percent confidence interval, 0.95 to1.21).
In an analysis restricted to subjects who had not smoked duringthe 10 years before the ultrasound evaluation, a history ofsmoking 10 or more years before the evaluation was associatedwith at least 25 percent carotid stenosis as compared with lessthan 25 percent stenosis in men (P = 0.038 for smoking 10 yearsearlier and P = 0.042 for smoking more than 10 years earlier)and women (P<0.001 and P = 0.065, respectively) (data notshown).
Additional age-adjusted logistic-regression analyses were undertakento test for factors associated with carotid stenosis of >50percent as compared with <50 percent. The results for >50percent and >25 percent stenosis tended to be similar inmen. On the other hand, the odds ratios in the current and time-integratedanalyses for >50 percent carotid stenosis were generallystronger for lipid factors in women. For instance, the oddsratio associated with an increase of 10 mg per deciliter incholesterol for women was 1.12 (95 percent confidence interval,1.04 to 1.21) for current levels and 1.22 (95 percent confidenceinterval, 1.13 to 1.32) for time-integrated levels. Similarly,the odds ratio associated with a one-unit increase in the ratioof total cholesterol to HDL cholesterol for women was 1.34 (95percent confidence interval, 1.13 to 1.59) for current levelsand 1.50 (95 percent confidence interval, 1.25 to 1.80) fortime-integrated levels.
Mean levels of systolic blood pressure in men and women whohad carotid evaluations at examination 20 are shown in Figure 1.Men and women with greater degrees of stenosis tended tohave higher systolic blood pressures throughout the 34 yearsof observation. Analogous figures for mean diastolic blood pressureare shown in Figure 2, and the corresponding data for mean cholesterollevels are shown in Figure 3. As with systolic blood pressure,higher mean cholesterol levels were associated with greaterdegrees of carotid stenosis. At biennial examination 20, however,these distributions were attenuated dramatically.
Figure 1. Mean Systolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).
Subjects were categorized according to the degree of carotid stenosis, and mean levels of systolic blood pressure are shown for the corresponding biennial examination.
Figure 2. Mean Diastolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).
Subjects were categorized according to the degree of carotid stenosis, and mean levels of diastolic blood pressure are shown for the corresponding biennial examination.
Figure 3. Mean Cholesterol Levels in Men and Women at 12 Biennial Examinations Spanning 34 Years, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).
Subjects were categorized according to the degree of carotid stenosis, and mean levels of cholesterol are shown for the corresponding biennial examination. To convert values for cholesterol to millimoles per liter, multiply by 0.02586.
Discussion
Several investigators have reported that the association betweenrisk factors and clinical coronary heart disease grows weakerin the elderly.17,18,24,25,26 For instance, young adults andmiddle-aged people with vascular disease commonly have highertotal cholesterol levels, but the apparent effect of cholesterolon vascular disease wanes after the age of 50 years and almostdisappears after 65.27 On the other hand, associations betweenHDL cholesterol and coronary heart disease tend to persist.26,28
Reports have also focused on associations between risk factorsand carotid abnormalities detected by ultrasonography.13,14,15,29,30,31Results often differ, and it is important to know the populationbeing studied, the age group, and the carotid abnormality described.For instance, among Finns 42 to 60 years of age, there werestrong associations between carotid stenosis and lipids (low-densitylipoprotein and HDL cholesterol) but no significant associationwith blood pressure.29 On the other hand, the AtherosclerosisRisk in Communities investigators, studying more than 7000 Americanmen and women 45 to 64 years of age, found relatively littlestenosis in their population sample. Those researchers focusedon significant correlations between preclinical disease, theintimal medial thickness of the carotid artery a diagnosticmeasure not available in the current study and a largevariety of risk factors, such as high lipoprotein levels, smoking,high blood pressure, high glucose levels, hematologic measures,and genetic markers.12,13,14 It is now accepted that the intimalmedial thickness of the distal common carotid artery is an indicatorof early atherosclerotic disease,32 although the zone of thickeningis distinct from the plaques that form in the proximal internalcarotid artery.33 The findings for moderate carotid stenosiswere emphasized in this report, although comparable findingswere available on the smaller number of people with severe stenosis.
This study emphasizes that contemporaneous measurements of systolicpressure, diastolic pressure, and smoking appear to be associatedwith moderate carotid stenosis in women but not in men. Associationsbetween risk factors and carotid stenosis were more consistentfor both sexes when time-integrated measurements of exposureover a period of 34 years were used. Similar dosedurationconcepts have been used to study familial hypercholesterolemiaand vascular disease in young adults. A person's lifetime cholesterollevel has been highly associated with the width of his or herAchilles' tendon as determined by computed tomography and withcalcified stenoses of coronary-vessel ostia as seen on ultrafastcomputed tomography.34,35,36 Recent reports have also demonstratedthat intimal medial thickening of the carotid bulb was presentin approximately 75 percent of middle-aged men and women withfamilial hypercholesterolemia.37
Carotid stenosis appears to be positively associated with currentsystolic pressure and inversely associated with current diastolicpressure in women (Table 3). Similar trends, though not statisticallysignificant, were observed in men. Such findings must be interpretedwith caution, because the time-integrated analyses of diastolicpressure tended to be positively associated with moderate carotidstenosis, although the results did not reach statistical significance.It is probable that elderly persons with known vascular diseaseare more likely to be receiving therapy for hypertension, andthe inverse effect of diastolic blood pressure may simply reflectintervention.
The strongly positive association between the time-integratedmeasurement of systolic pressure and carotid stenosis is a reminderof the importance of systolic pressure in determining the riskof vascular disease. For instance, the systolic pressure wasmore highly associated with coronary heart disease and strokethan the diastolic pressure in the Framingham Heart Study.38,39Although clinical practice typically emphasizes the role ofdiastolic pressure, this finding underscores the importanceof systolic pressure and its role in increasing the risk ofclinical and subclinical sequelae of vascular disease.
The relation between vascular disease and the time-integratedmeasurement of a risk factor can be expected to be strongerthan the association with a single measurement for a varietyof reasons. Multiple measurements of the same variable may classifypersons more accurately, because there may be significant laboratoryor biologic variation in the factor under consideration andrisk-factor levels may change unpredictably among older persons.40,41,42Laboratory methods were relatively uniform over the course ofthe study. Cholesterol and HDL cholesterol were generally measuredin the nonfasting state, and the reported difference betweenmeasurements of these analytes in the fasting and nonfastingstates is minimal.41,43 Laboratory methods also evolved overtime, but quality control of the enzymatic measurements of lipoproteincholesterol was linked to the AbellKendall methods thatwere in use during the study.41,44
This study was based on the survivors of a long-term observationalinvestigation. Cholesterol levels often decline in the elderly,and single measurements in an older subject may misrepresentexposure.45 The importance of multiple measurements and time-integratedeffects may be particularly evident when levels or habits change.The association of cigarette smoking with carotid stenosis ismore complex, because long-term exposure is highly associatedwith stenosis and smoking cessation 10 years before the carotidevaluation was still associated with carotid stenosis in theseanalyses.
There are preventive implications of the significant associationsbetween carotid stenosis and time-integrated measurements oftraditional risk factors. Lower blood pressure, lower cholesterollevels, and abstention from smoking in middle adulthood mightlead to less carotid stenosis in the elderly, along with lesscoronary heart disease and stroke.
Supported by the National Heart, Lung, and Blood Institute'sFramingham Heart Study (contract N01-HC-38038) and by a grant(5R01-NS17950) from the National Institutes of Health.
Source Information
From the Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass. (P.W.F.W.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (J.M.H.); and the Department of Mathematics, Boston University (R.B.D., H.S., A.M.B.), the Department of Neurology, Boston University School of Medicine (H.P., P.A.W.), and the Department of Radiology, Tufts University Medical Center (D.O.) all in Boston.
Address reprint requests to Dr. Wilson at the Framingham Heart Study, National Heart, Lung, and Blood Institute, 5 Thurber St., Framingham, MA 01701.
References
Stamler J, Wentworth DN, Neaton JD. Is the relationship between serum cholesterol and risk of death from coronary heart disease continuous and graded? Findings on the 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-2828. [Abstract]
Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:357-362.
Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13:Suppl:I-2.
O'Leary DH, Anderson KM, Wolf PA, Evans JC, Poehlman HW. Cholesterol and carotid atherosclerosis in older persons: the Framingham Study. Ann Epidemiol 1992;2:147-153. [Medline]
Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995;91:284-290. [Free Full Text]
Fabris F, Zanocchi M, Bo M, et al. Carotid plaque, aging, and risk factors: a study of 457 subjects. Stroke 1994;25:1133-1140. [Abstract]
Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991;266:3289-3294. [Abstract]
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453. [Abstract]
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428. [Abstract]
Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol 1995;75:455-459. [Erratum, J Cardiol 1995;75:862.] [CrossRef][Medline]
The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-212. [Medline]
Folsom AR, Eckfeldt JH, Weitzman S, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 1994;25:66-73. [Abstract]
Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1558-1566. [Free Full Text]
Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-1104. [Free Full Text]
Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking with carotid artery wall thickness and stenosis in older adults: the Cardiovascular Health Study: the Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1994;90:2905-2908. [Free Full Text]
Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995;92:2142-2150. [Free Full Text]
Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990;263:393-396. [Abstract]
Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke 1994;25:814-820. [Abstract]
McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8. [CrossRef][Medline]
Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195:357-366. [Free Full Text]
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-2180. [Abstract]
Testing hypotheses in multiple regression. In: Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWSKent Publishing, 1988:124-43.
The multiple logistic regression model. In: Hosmer DW Jr, Leme-show S. Applied logistic regression. New York: John Wiley, 1989:25-37.
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707-714. [CrossRef][Medline]
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons: the Framingham Study. JAMA 1977;238:497-499. [Abstract]
Wilson PWF, Kannel WB. Hypercholesterolemia and coronary risk in the elderly: the Framingham Study. Am J Geriatr Cardiol 1993;2(2):52-6.
Kannel WB, Castelli WP. Is the serum total cholesterol an anachronism? Lancet 1979;2:950-951. [Medline]
Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988;8:788-792. [Free Full Text]
Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991;134:250-256. [Free Full Text]
O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke 1992;23:1752-1760. [Free Full Text]
O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 1996;27:224-231. [Free Full Text]
Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thromb 1994;14:261-264. [Free Full Text]
Hoeg JM. Familial hypercholesterolemia: what the zebra can teach us about the horse. JAMA 1994;271:543-546. [CrossRef][Medline]
Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 1994;14:1066-1074. [Free Full Text]
Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996;77:575-580. [CrossRef][Medline]
Sidhu PS, Naoumova RP, Maher VMG, et al. The extracranial carotid artery in familial hypercholesterolaemia: relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease. J Cardiovasc Risk 1996;3:61-67. [CrossRef][Medline]
Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham Study. JAMA 1981;245:1225-1229. [Abstract]
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264. [Abstract]
Wilson PWF. Cholesterol screening: once is not enough. Arch Intern Med 1995;155:2146-2147. [CrossRef][Medline]
Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements: variations and practical utility. JAMA 1992;267:1652-1660. [Abstract]
Cooper GR, Smith SJ, Myers GL, Sampson EJ, Magid E. Estimating and minimizing effects of biologic sources of variation by relative range when measuring the mean of serum lipids and lipoproteins. Clin Chem 1994;40:227-232. [Free Full Text]
LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation 1990;81:1721-1733. [Free Full Text]
Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Clin Chem 1988;34:193-201. [Free Full Text]
Wilson PWF, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994;49:M252-M257. [Medline]
Pletcher, M. J., Bibbins-Domingo, K., Lewis, C. E., Wei, G. S., Sidney, S., Carr, J. J., Vittinghoff, E., McCulloch, C. E., Hulley, S. B.
(2008). Prehypertension during Young Adulthood and Coronary Calcium Later in Life. ANN INTERN MED
149: 91-99
[Abstract][Full Text]
Crawford, D. C., Nord, A. S., Badzioch, M. D., Ranchalis, J., McKinstry, L. A., Ahearn, M., Bertucci, C., Shephard, C., Wong, M., Rieder, M. J., Schellenberg, G. D., Nickerson, D. A., Heagerty, P. J., Wijsman, E. M., Jarvik, G. P.
(2008). A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk. J. Lipid Res.
49: 588-596
[Abstract][Full Text]
Sheikh, K.
(2008). Total Cholesterol, Severity of Stroke, and All-Cause Mortality. Stroke
39: e61-e62
[Full Text]
Wolff, T., Guirguis-Blake, J., Miller, T., Gillespie, M., Harris, R.
(2007). Screening for Carotid Artery Stenosis: An Update of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED
147: 860-870
[Abstract][Full Text]
Crouse, J. R. III
(2006). Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art. J. Lipid Res.
47: 1677-1699
[Abstract][Full Text]
Jae, S. Y., Fernhall, B., Heffernan, K. S., Kang, M., Lee, M.-K., Choi, Y.-H., Park, W. H.
(2006). Chronotropic response to exercise testing is associated with carotid atherosclerosis in healthy middle-aged men. Eur Heart J
27: 954-959
[Abstract][Full Text]
Amarenco, P., Labreuche, J., Lavallee, P., Touboul, P.-J.
(2004). Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis. Stroke
35: 2902-2909
[Abstract][Full Text]
Karp, I., Abrahamowicz, M., Bartlett, G., Pilote, L.
(2004). Updated Risk Factor Values and the Ability of the Multivariable Risk Score to Predict Coronary Heart Disease. Am J Epidemiol
160: 707-716
[Abstract][Full Text]
Curb, J. D., Abbott, R. D., Rodriguez, B. L., Masaki, K. H., Chen, R., Popper, J. S., Petrovitch, H., Ross, G. W., Schatz, I. J., Belleau, G. C., Yano, K.
(2004). High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program. Am J Epidemiol
160: 150-157
[Abstract][Full Text]
Dodick, D. W., Meissner, I., Meyer, F. B., Cloft, H. J.
(2004). Evaluation and Management of Asymptomatic Carotid Artery Stenosis. Mayo Clin. Proc.
79: 937-944
[Abstract]
Amarenco, P., Tonkin, A. M.
(2004). Statins for Stroke Prevention: Disappointment and Hope. Circulation
109: III-44-III-49
[Abstract][Full Text]
Oei, H.-H. S., Vliegenthart, R., Hofman, A., Oudkerk, M., Witteman, J. C.M.
(2004). Risk factors for coronary calcification in older subjects: The Rotterdam Coronary Calcification Study. Eur Heart J
25: 48-55
[Abstract][Full Text]
Li, S., Chen, W., Srinivasan, S. R., Bond, M. G., Tang, R., Urbina, E. M., Berenson, G. S.
(2003). Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The Bogalusa Heart Study. JAMA
290: 2271-2276
[Abstract][Full Text]
Greenland, P., Knoll, M. D., Stamler, J., Neaton, J. D., Dyer, A. R., Garside, D. B., Wilson, P. W.
(2003). Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA
290: 891-897
[Abstract][Full Text]
Oren, A., Vos, L. E., Uiterwaal, C. S. P. M., Grobbee, D. E., Bots, M. L.
(2003). Cardiovascular Risk Factors and Increased Carotid Intima-Media Thickness in Healthy Young Adults: The Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med
163: 1787-1792
[Abstract][Full Text]
Tan, Z. S., Seshadri, S., Beiser, A., Wilson, P. W. F., Kiel, D. P., Tocco, M., D'Agostino, R. B., Wolf, P. A.
(2003). Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease: The Framingham Study. Arch Intern Med
163: 1053-1057
[Abstract][Full Text]
Spence, J. D., Eliasziw, M., DiCicco, M., Hackam, D. G., Galil, R., Lohmann, T.
(2002). Carotid Plaque Area: A Tool for Targeting and Evaluating Vascular Preventive Therapy. Stroke
33: 2916-2922
[Abstract][Full Text]
Bild, D. E., Bluemke, D. A., Burke, G. L., Detrano, R., Diez Roux, A. V., Folsom, A. R., Greenland, P., JacobsJr., D. R., Kronmal, R., Liu, K., Nelson, J. C., O'Leary, D., Saad, M. F., Shea, S., Szklo, M., Tracy, R. P.
(2002). Multi-Ethnic Study of Atherosclerosis: Objectives and Design. Am J Epidemiol
156: 871-881
[Abstract][Full Text]
Crouse, J. R. III, Tang, R., Espeland, M. A., Terry, J. G., Morgan, T., Mercuri, M.
(2002). Associations of Extracranial Carotid Atherosclerosis Progression With Coronary Status and Risk Factors in Patients With and Without Coronary Artery Disease. Circulation
106: 2061-2066
[Abstract][Full Text]
Wang, T. J., Nam, B.-H., Wilson, P. W.F., Wolf, P. A., Levy, D., Polak, J. F., D'Agostino, R. B., O'Donnell, C. J.
(2002). Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study. Arterioscler. Thromb. Vasc. Bio.
22: 1662-1667
[Abstract][Full Text]
Bolego, C., Poli, A., Paoletti, R.
(2002). Smoking and gender. Cardiovasc Res
53: 568-576
[Abstract][Full Text]
Sheikh, K., Mathiesen, E. B., Bonaa, K. H., Joakimsen, O.
(2002). Cholesterol and Carotid Stenosis. Stroke
33: 321-322
[Full Text]
Vasan, R. S., Massaro, J. M., Wilson, P. W.F., Seshadri, S., Wolf, P. A., Levy, D., D'Agostino, R. B.
(2002). Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study. Circulation
105: 48-53
[Abstract][Full Text]
Davis, P. H., Dawson, J. D., Riley, W. A., Lauer, R. M.
(2001). Carotid Intimal-Medial Thickness Is Related to Cardiovascular Risk Factors Measured From Childhood Through Middle Age: The Muscatine Study. Circulation
104: 2815-2819
[Abstract][Full Text]
Seshadri, S., Wolf, P. A., Beiser, A., Vasan, R. S., Wilson, P. W. F., Kase, C. S., Kelly-Hayes, M., Kannel, W. B., D'Agostino, R. B.
(2001). Elevated Midlife Blood Pressure Increases Stroke Risk in Elderly Persons: The Framingham Study. Arch Intern Med
161: 2343-2350
[Abstract][Full Text]
Sheikh, K., Sacco, R. L., Boden-Albala, B.
(2001). High-Density Lipoprotein Cholesterol and Risk of Stroke. JAMA
286: 1573-1574
[Full Text]
Amarenco, P.
(2001). Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction. Neurology
57: S35-44
[Abstract][Full Text]
Forsblad, J, Gottsater, A, Matzsch, T, Lindgarde, F
(2001). Predictors of carotid endarterectomy in middle-aged individuals. Vasc Med
6: 81-85
[Abstract]
Drouilhet, J. C. III, Southern, F., Williams, D. K., Brown, A. T., Eidt, J., Moursi, M. M.
(2001). Increased Intimal Hyperplasia After Carotid Endarterectomy in Spontaneously Hypertensive Rats. VASC ENDOVASCULAR SURG
35: 11-18
[Abstract]
Meigs, J. B.
(2000). Invited Commentary: Insulin Resistance Syndrome? Syndrome X? Multiple Metabolic Syndrome? A Syndrome At All? Factor Analysis Reveals Patterns in the Fabric of Correlated Metabolic Risk Factors. Am J Epidemiol
152: 908-911
[Abstract][Full Text]
Wilfert, K., Drischel, K., Unbehaun, A., Guski, H., Persson, P. B., Stauss, H. M.
(2000). Vascular Response to Angiotensin II in Atherosclerosis : Role of the Baroreflex. Hypertension
35: 685-690
[Abstract][Full Text]
Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., Willeit, J.
(1999). Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: Prospective results from the bruneck study. J Am Coll Cardiol
34: 1975-1981
[Abstract][Full Text]
Anderson, J. W, Smith, B. M, Washnock, C. S
(1999). Cardiovascular and renal benefits of dry bean and soybean intake. Am. J. Clin. Nutr.
70: 464S-474
[Abstract][Full Text]
Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P., Clayton, R. N.
(1999). Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults. J. Clin. Endocrinol. Metab.
84: 453-457
[Abstract][Full Text]
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., Wolfson, S. K., The Cardiovascular Health Study Collaborative Rese,
(1999). Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults. NEJM
340: 14-22
[Abstract][Full Text]